Dr Reddys Laboratories Ltd


BSE: 500124 | NSE: DRREDDY | ISIN: INE089A01023 
Market Cap: [Rs.Cr.] 34,293 | Face Value: [Rs.] 5
Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

 Discuss this stock

Board Meet

14-May-13 
Dr Reddys Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 14, 2013, inter alia, to consider and approve the Audited Financial Results of the Company for the financial year ended March 31, 2013 and recommend dividend, if any, for the financial year 2012-13. Dr Reddys Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 14, 2013, inter alia, has recommended a final dividend of Rs. 15/- (300%) per equity share of Rs. 5/- face value, for the financial year 2012-13. The dividend on equity shares, if declared by the shareholders at the ensuing Annual Genera! Meeting, will be credited / despatched on or after August 07, 2013. (As per BSE Announcement Dated on 14.05.2013) 
14-Feb-13 
Dr Reddys Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 14, 2013, inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2012. 
30-Oct-12 
Dr Reddys Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on October 30, 2012, inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and half-year ended September 30, 2012 (Q2). 
19-Jul-12 
Quarterly Results 
11-May-12 
Dr Reddys Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 11, 2012, inter alia, to consider and approve the Audited Financial Results of the Company for the year ended March 31, 2012 and recommend dividend, if any, for the financial year 2011-12. Dr Reddys Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 11, 2012, inter alia, have recommended a final dividend of Rs. 13.75 (275%) per equity share of Rs. 5/- face value, for the financial year 2011-12. The dividend on equity shares, if declared by the shareholders at the ensuing Annual General Meeting, will be credited / dispatched on or after July 27, 2012. (As Per BSE Announcement Website Dated on 11/05/2012) 

AGM

31-Jul-13
AGM : 31.07.2013 Scrip Code : 400124, 600124 
20-Jul-12
Dr Reddys Laboratories Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from July 03, 2012 to July 06, 2012 (both days inclusive) for the purpose of Payment of Final Dividend & Annual General Meeting (AGM) of the Company to be held on July 20, 2012. Dr Reddys Laboratories Ltd has informed BSE that the 28th Annual General Meeting (AGM) of the Company will be held on July 20, 2012. (As Per BSE Announcement Website Dated on 29/06/2012) Dr Reddys Laboratories Ltd has informed BSE that the 28th Annual General Meeting (AGM) of the Company was held on July 20, 2012. (As Per BSE Announcement Website Dated on 20/07/2012) 
21-Jul-11
Dr Reddys Laboratories Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from July 05, 2011 to July 09, 2011 (both days inclusive) for the purpose of Payment of Dividend & Annual General Meeting (AGM) of the Company to be held on July 21, 2011. Dr Reddys Laboratories Ltd has informed BSE that the 27th Annual General Meeting (AGM) of the Company was held on July 21, 2011. (As Per BSE Annoncement Website Dated on 21/07/2011) 
23-Jul-10
Dr Reddys Laboratories Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from July 06, 2010 to July 10, 2010 (both days inclusive) for the purpose of Annual General Meeting (AGM) of the Company to be held on July 23, 2010. Dr Reddys Laboratories Ltd has informed BSE that the dividend, which may be declared at the Annual General Meeting scheduled to be held on July 23, 2010, shall be paid to the shareholders on or after July 30, 2010. (As Per BSE Announcement Website dated on 29.06.2010) Dr Reddys Laboratories Ltd has informed BSE that the members at the 26th Annual General Meeting (AGM) of the Company held on July 23, 2010, have approved all the items set out in the notice dated June 03, 2010, convening the said AGM, as under: 1. The Balance Sheet as at March 31, 2010 and the Profit & Loss Account of the Company for the year ended on that date, along with the Directors Report and Auditor's Report thereon. 2. Payment of dividend @ Rs. 11.25 per equity share of Rs. 5/- each (225%) of the Company. 3. Re-appointment of Dr. J P Moreau & Ms. Kalpana Morparia, as Directors of the Company. 4. Appointment of M/s. B S R & Co., Chartered Accountants as Auditors of the Company, to hold office till the conclusion of the next Annual General Meeting, on such remuneration as may be decided by the Board of Directors. 5. Appointment of Dr. Ashok Sekhar Ganguly, as a Director of the Company. (As Per BSE Announcement Website dated on 23.07.2010) 
22-Jul-09
Dr Reddys Laboratories Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from July 07, 2009 to July 11, 2009 (both days inclusive) for the purpose of Annual General Meeting (AGM) of the Company to be held on July 22, 2009. Dr Reddys Laboratories Ltd has informed BSE that the members at the 25th Annual General Meeting (AGM) of the Company held on July 22, 2009, inter alia, have accorded to the following: 1. The Balance Sheet as at March 31, 2009 and the Profit & Loss Account of the Company for the year ended on that date, along with the Director's Report and Auditor's Report thereon. 2. Payment of dividend @ Rs 6.25 per equity share of Rs 5/- each (125%) of the Company. 3. Re-appointment of Dr. Omkar Goswami, as a Director of the Company. 4. Re-appointment of Mr. Ravi Bhoothalingam, as a Director of the Company. 5. Appointment of M/s. B S R & Co., Chartered Accountants as Auditors of the Company, to hold office till the conclusion of the next Annual General Meeting, on such remuneration as may be decided by the Board of Directors. 6. Appointment of Dr. Bruce LA Carter, as a Director of the Company. (As Per BSE Announcement Website dated on 22.07.2009) 

EGM

28-May-10
Dr Reddys Laboratories Ltd has informed BSE that by an order dated April 21, 2010, the Hon'ble High Court of Andhra Pradesh has directed that a meeting of the members of the Company will be held on May 28, 2010., for the purpose of considering and if thought (it, approving, with or without modification, the Scheme of Arrangement proposed to be made between the Dr Reddys Laboratories Ltd (Applicant Company) and its members for the issue of unsecured, redeemable, non-convertible, fully paid up bonus debentures of the Applicant Company from its general reserve to its members. Dr Reddys Laboratories Ltd has informed BSE that at the Court Convened Meeting held on May 28, 2010 pursuant to the Order of the Hon'ble High Court at Judicature of Andhra Pradesh at Hyderabad dated April 21, 2010 passed in C.A. No. 286 of 2010, the shareholders of the Company have approved the proposed Scheme of Arrangement of the Company for issuance of bonus debentures with requisite majority. (As Per BSE Announcement Website dated on 28.05.2010) 

Peer Comparison

Company Market Cap
(Rs. in Cr.)
P/E (TTM)
(x)
P/BV (TTM)
(x)
EV/EBIDTA
(x)
ROE
(%)
ROCE
(%)
D/E
(x)
Sun Pharma.Inds. 100,831.19 70.05 12.43 27.45 26.1 27.0 0.01
Dr Reddy's Labs 34,293.45 27.10 4.50 18.79 14.3 16.6 0.25
Cipla 33,488.96 21.87 4.44 14.11 15.9 19.8 0.03
Ranbaxy Labs. 18,461.97 0.00 9.61 72.87 0.0 0.0 2.38
Wockhardt 18,451.08 109.91 153.35 12.82 237.0 30.3 2.09
Cadila Health. 16,135.56 39.11 6.33 18.45 28.4 24.2 0.40
Glenmark Pharma. 15,542.89 40.26 6.16 23.94 12.7 11.7 0.39
Piramal Enterp. 9,821.55 0.00 0.93 23.66 0.8 2.1 0.07
Ipca Labs. 7,445.80 22.39 5.90 10.09 24.2 23.7 0.49
Torrent Pharma. 6,124.37 11.45 4.69 11.66 29.6 25.5 0.48
Biocon 5,645.00 19.68 2.56 12.20 12.6 13.6 0.08
Aurobindo Pharma 5,264.90 12.52 2.11 22.89 10.7 8.8 1.01
Strides Arcolab 5,195.22 35.42 3.79 46.94 7.3 8.9 0.56
Mylan Lab. 3,273.19 6.80 1.77 0.00 26.9 26.1 0.59
Alembic Pharma 2,406.20 15.29 5.23 5.60 39.5 27.7 1.07

Futures & Options Quote

 
Expiry Date
2027.90 24.50  [1.2]%
Instrument: FUTSTK
Expiry Date: 30 May 2013
Open Price: 2,063.40
Average Price: 2,036.39
No. of Contracts Traded: 227,500
Open Interest: 852,625
Underlying: DRREDDY
Market Lot: 125
Previous Close: 2,027.90
Day’s High | Low: 2,070.90 | 2,022.65
Turnover (Cr.): 46.33
Open Int. Change: 18,750.00 (2.3% )
View detailed F& O quotes >>

Key Information

Key Executives:

G V Prasad , Chairman & CEO  

Satish Reddy , Vice Chairman & M.D.  

Anupam Puri , Director  

J P Moreau , Director  


Company Head Office / Quarters:
8-2-337 Road No 3,
Banjara Hills,
Hyderabad,
Andhra Pradesh-500034
Phone : 91-40-49002900
Fax : 91-40-49002999
E-mail : shares@drreddys.com
Web : http://www.drreddys.com
Registrars:
Big Share Services Pvt Ltd
3rd Flr 306 Rightwin
Amrutha Ville
Somajiguda
Hyderabad-500082

Calendar

May-2013
M T W T F S S
20 21 22 23 24 25 26
IPO
listIssue Open : Just Dial
listIssue Closing : Onesource Techm.
Economic Events
list Adjusted Merchandise Trade Balance (Yen)
list Merchandise Trade Balance Total (Yen)
Results
list Tech Mahindra